News & Events



OneOme Announces New Specimen Option to Further Bring Its Powerful Pharmacogenomic Test into Routine Clinical Care

MINNEAPOLIS (March 13, 2017) – OneOme today announced that healthcare providers now are able to order OneOme’s RightMed® pharmacogenomic test as part of an ordinary blood panel. Previously, the RightMed test was only available through a cheek swab. Making testing available using blood will furt...

READ MORE

MinnPost: Right the first time: How a Minneapolis company uses DNA tests to limit the side effects of psychiatric meds

MinnPost published an article recounting the story of how OneOme’s RightMed pharmacogenomic test helped identify an effective prescription treatment for a teenager struggling with mental health conditions.

For 10 years Carly and her family searched for the right medications and doses for her a...

READ MORE

During Heart Month, OneOme Highlights How RightMed® Pharmacogenomic Test Can Help People Taking Heart Medications

RightMed Pharmacogenomic Test is a New Way for Your Physician to Improve the Effectiveness of Your Cardiovascular Prescriptions

MINNEAPOLIS (Feb. 1, 2017) – This Heart Month, people suffering from heart conditions have a new opportunity to improve the effectiveness of their cardiovascular treatments through their healthcare provider: OneOme’s RightMed pharmacogenomic test. The RightMed test uses the power of DNA to minim...

READ MORE

Pharmacogenomics Company OneOme Announces Leadership Promotions

Jason Ross will Serve as Chief Technology Officer, Josiah Allen Promoted to Director of Medical Affairs

MINNEAPOLIS (Jan. 26, 2017) – Pharmacogenomics company OneOme announced today that Jason Ross will serve as its chief technology officer and that Josiah Allen was promoted to OneOme’s director of medical affairs.

“We are glad to add Josiah Allen and Jason Ross to our leadership team,” said Pa...

READ MORE

Pharmacogenomics Company OneOme Announces Patent-Pending Status for RightMed® Test and RightMed Advisor

MINNEAPOLIS (Jan. 10, 2017) – Pharmacogenomics company OneOme today announced the U.S. Patent and Trademark office has issued “Patent Pending” status for its RightMed pharmacogenomic test and RightMed Advisor, an online tool for providers to quickly and easily interpret test results and gain a...

READ MORE